Sucampo Pharmaceuticals, Inc.·4

May 30, 4:58 PM ET

Getman Daniel P 4

4 · Sucampo Pharmaceuticals, Inc. · Filed May 30, 2013

Insider Transaction Report

Form 4
Period: 2013-05-22
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2013-05-22+20,00070,000 total
    Exercise: $8.62Exp: 2023-05-22Class A Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The options vest in twelve equal monthly installments.

Documents

1 file
  • 4
    form460079_20130530045752-.xmlPrimary